Chinese COVID-19 vaccine enters third-stage human trial
BEIJING: A leading Chinese vaccine maker said it has commenced phase-3 clinical trials for its COVID-19 vaccine and is planning to recruit 29,000 volunteers across the world. This is China’s first phase-3 efficacy study for a Recombinant subunit COVID-19 vaccine candidate, Anhui Zhifei Longcom Biopharmaceutical, said in a statement on Thursday. Jointly developed by the … Read more